Patents by Inventor Kenneth A. Newlander

Kenneth A. Newlander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fab I inhibitors
    Publication number: 20060116394
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Application
    Filed: November 22, 2005
    Publication date: June 1, 2006
    Inventors: Walter Burgess, Dalia Jakas, William Huffman, William Miller, Kenneth Newlander, Mark Seefeld, Irene Uzinskas
  • Fab I inhibitors
    Patent number: 7049310
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: May 23, 2006
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Walter J. Burgess, Dalia Jakas, William F. Huffman, William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas
  • Compounds, compositions and methods
    Publication number: 20060052360
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: December 12, 2003
    Publication date: March 9, 2006
    Inventors: Gustave Bergnes, Dashyant Dhanak, Steven Knight, Pu Lu, David Morgans, Kenneth Newlander
  • Compounds, compositions and methods
    Publication number: 20060020008
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: June 15, 2005
    Publication date: January 26, 2006
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David Morgans, Steven Knight, Kenneth Newlander, Dashyant Dhanak, Christopher Brook
  • Antibacterial compounds
    Patent number: 6964970
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections: wherein: R1 is Ar or Het; R2 is H, C1-6alkyl or Ar-C0-6alkyl; X is H, C1-4alkyl, OR?, SR?, C1-4alkylsulfonyl, C1-4alkylsulfoxyl, CN, N(R?)2, CH2N(R?) 2, NO2, CF3, CO2R?, CON(R?)2, COR?, NR?C(O)R?, F, Cl, Br, I, or CF3S(O)r—; R? is H, C1-6alkyl or Ar-C0-6alkyl; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: November 15, 2005
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark Seefeld
  • FAB I inhibitors
    Publication number: 20050250810
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Application
    Filed: December 9, 2004
    Publication date: November 10, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: William Miller, Kenneth Newlander, Mark Seefeld, Irene Uzinskas, Walter DeWolf, Dalia Jakas
  • Compounds, compositions and methods
    Patent number: 6924376
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: August 2, 2005
    Assignees: Cytokinetics, Inc., Smithkline Beecham Corporation
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David J. Morgans, Jr., Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Christopher A. Brook
  • Fab I inhibitors
    Patent number: 6846819
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: January 25, 2005
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Walter E. DeWolf, Jr., Dalia R. Jakas
  • Fab I inhibitors
    Publication number: 20040147580
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Application
    Filed: October 6, 2003
    Publication date: July 29, 2004
    Inventors: Walter J. Burgess, Dalia Jakas, William F Huffmann, William H Miller, Kenneth A Newlander, Mark A Seefeld, Irene N Uzinskas
  • Fab I inhibitors
    Patent number: 6765005
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections:
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: July 20, 2004
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld
  • Fab I inhibitors
    Patent number: 6762201
    Abstract: Compounds of the formula (I) are disclosed which are FabI inhibitors and are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: July 13, 2004
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld
  • Fab I inhibitors
    Patent number: 6730684
    Abstract: Compounds of formula (I) and (II) are disclosed wherein, R1, R2, R3, R4, X, A, B, D and Q are as disclosed in the specification, and the compounds are FabI inhibitors useful in the treatment of bacterial infections.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: May 4, 2004
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas
  • Compounds, compositions and methods
    Publication number: 20040082638
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: April 11, 2003
    Publication date: April 29, 2004
    Applicant: Cytokinetics, Inc.
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David J. Morgans, Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Christopher A. Brook
  • Compounds, methods and compositions
    Publication number: 20040077662
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: May 2, 2003
    Publication date: April 22, 2004
    Applicant: Cytokinetics, Inc.
    Inventors: Han-Jie Zhou, David J. Morgans, Gustave Bergnes, Steven David Knight, Kenneth A. Newlander, Dashyant Dhanak, Nicholas D. Adams
  • Disubstituted imidazoles useful in the treatment of bacterial infections
    Patent number: 6673941
    Abstract: Compounds of formula (I) and formula (II) are disclosed which are useful in the treatment bacterial infections: wherein: R1 is C1-4alkyl, Ar or 2-thienyl or 3-thienyl; R2 is C1-4alkyl or Ar; and n is 0-3; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 9, 2003
    Date of Patent: January 6, 2004
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Dirk Heerding, Kenneth A. Newlander
  • Antibacterial compounds
    Publication number: 20030232850
    Abstract: Compounds of formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections, wherein: R1 is Ar or Het; R2 is H, C1-6alkyl or Ar—C0-6alkyl; X is H, C1-4alkyl, OR′, SR′, C1-4alkylsulfonyl, C1-4alkylsulfonyl, CN, N(R′)2, CH2N(R′)2, NO2, CF3, CO2R′, CON(R′)2, COR′, NR′C(O)R′, F, Cl, Br, I, or CF3S(O)r; R′ is H, C1-6alkyl or Ar—C0-6alkyl; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 5, 2003
    Publication date: December 18, 2003
    Inventors: William H. Miller, Kenneth A. Newlander, Mark Seefeld
  • Antibacterial compounds
    Publication number: 20030149089
    Abstract: Compounds of formula (I) and formula (II) are disclosed which are useful in the treatment bacterial infections: 1
    Type: Application
    Filed: January 9, 2003
    Publication date: August 7, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Dirk Heerding, Kenneth A. Newlander
  • Fab I inhibitors
    Publication number: 20030139377
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections: 1
    Type: Application
    Filed: November 12, 2002
    Publication date: July 24, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld
  • Antibacterial compounds
    Patent number: 6573272
    Abstract: Compounds of the formula (I) are disclosed which are FabI inhibitors and are useful in the treatment bacterial infections: wherein: R1 is Ar or Het; R2 is H, C1-6alkyl or Ar—C0-6alkyl; X is H, C1-4alkyl, OR′, SR′, C1-4alkylsulfonyl, C1-4alkylsulfoxyl, CN, N(R′)2, CH2N(R′)2, NO2, CF3, CO2R′, CON(R′)2, COR′, NR′C(O)R′, F, Cl, Br, I, or CF3S(O)r—; R′ is H, C1-6alkyl or Ar—C0-6alkyl; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: June 3, 2003
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark Seefeld
  • Disubstituted imidazoles useful in the treatment of bacterial infections
    Patent number: 6559172
    Abstract: Novel disubstituted imidazoles are disclosed which are useful in the treatment of bacterial infections, particularly through the inhibition of FAB I.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: May 6, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Dirk Heerding, Kenneth A. Newlander